The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1084/jem.20070822
The Journal of Experimental Medicine, Vol. 204, No. 9, 2039-2045
The Rockefeller University Press, 0022-1007 $30.00
© Wong et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3034K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, J.
Right arrow Articles by Benoist, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, J.
Right arrow Articles by Benoist, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Brief Definitive Report

 TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets

Jamie Wong1,2,3, Diane Mathis1,2,3, and Christophe Benoist1,2,3

1 Section on Immunology and Immunogenetics, Joslin Diabetes Center; 2 Department of Medicine, Brigham and Women's Hospital, 3 Harvard Medical School, Boston, MA 02215

CORRESPONDENCE Diane Mathis OR Christophe Benoist: cbdm{at}joslin.harvard.edu

Foxp3-expressing regulatory T (T reg) cells derive primarily from selection in the thymus. Yet conversion of mature conventional CD4+ T (T conv) cell lymphocytes can be achieved in several conditions, such as transforming growth factor β treatment, homeostatic expansion, or chronic exposure to low-dose antigen. Such conversion might provide a means to generate peripheral tolerance by "converting" potentially damaging T cells that react to self-antigens. We tested this hypothesis in mice transgenic for the BDC2.5 T cell receptor (TCR), which is representative of a diabetogenic specificity that is naturally present in NOD mice and reactive against a pancreatic self-antigen. In the thymus, before any exposure to antigen, clonotype-positive T reg and T conv cells express a second TCR{alpha} chain derived from endogenous loci. High-throughput single-cell sequencing of secondary TCRs of the V{alpha}2 family showed their joining CDR3{alpha} regions to be very different in T reg and T conv cell thymocytes. These specific CDR3{alpha} motifs, thus, provided a "tag" with which to test the actual impact of T conv to T reg cell conversion in response to peripheral self-antigen; should the autoreactive clonotypic TCR induce T conv to T reg cell conversion upon encounter of cognate antigen in the pancreas or draining lymph node, one would expect to detect tag CDR3{alpha} motifs from T conv cells in the T reg cell populations. Sequencing large numbers of peripheral BDC+V{alpha}2+ cells showed that little to no conversion occurs in response to this pancreatic autoantigen.

Abbreviations used: ACE, abundance-based coverage estimator; CDR, complementarity determining region; MH, Morisita–Horn; PLN, pancreas-draining LN; T conv, conventional CD4+ T cell; tg, transgenic.

The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS